Skip to content
A leading Australian kidney specialist will take the helm at the Northern Territory's Menzies School of Health Research (Menzies), following a six-month global search for a world-class director and health researcher.
Professor Alan Cass, a senior director at Sydney's the George Institute, and an Australian Indigenous HealthInfoNet consultant, was today announced as the new head of the nation's only medical research institute with a major focus on tropical and Indigenous health.
Chair of the Menzies' Board, Professor Simon Maddocks, said Professor Cass was an ideal candidate.
'Professor Cass has a deep understanding of Indigenous health and Indigenous communities developed through his extensive career as a kidney health researcher. He takes an especially collaborative approach to health research, and that is of vital importance to Menzies.
'We are confident Professor Cass will continue to strengthen Menzies' goal to improve health outcomes for populations across Australia and in the Asia Pacific region, he has significant links nationally and globally - particularly throughout Asia.'
Professor Cass currently serves as the Director of the Renal Division at the prestigious George Institute for Global Health in Sydney.
He is also a member of the Executive of the Australasian Kidney Trials Network; the President-Elect for the Australian and New Zealand Society of Nephrology; and a leading proponent of academic collaboration in clinical research in kidney disease.
In 2003, Professor Cass completed a Harkness Fellowship at Harvard University in the USA.
Professor Cass has authored an average of 20 academic papers per year, fuelled by a strident commitment to prevent chronic disease and advance wellbeing among Aboriginal and Torres Strait Island Australians.
He is also a Chief Investigator for the Kanyini Vascular Collaboration, which brings together researchers, health providers and communities across Australia to conduct research to improve health outcomes for Aboriginal and Torres Strait Islander Australians with heart disease, diabetes and kidney disease.
Professor Cass will relocate to Menzies' Darwin headquarters on 12 November.
The Australian Indigenous HealthInfoNet congratulates Professor Cass on his appointment.